Learn More
ATCC Pseudomonas aeruginosa; Strain PGO2354
Supplier: ATCC BAA2111

Pseudomonas aeruginosa strain PGO2354 was collected from a sputum sample of a cystic fibrosis patient during a Phase III clinical trial that tested the effectiveness of aerosolized Tobi (Tobramycin). This whole-genome sequenced strain is propagated aerobically in trypticase soy medium and is used for drug development research.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.